A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V600 mutation positive metastatic melanoma
====================================================================================================================================================

* Joseph I. Clark
* Jatinder Singh
* Marc S. Ernstoff
* Christopher D. Lao
* Lawrence E. Flaherty
* Theodore F. Logan
* Brendan Curti
* Sanjiv S. Agarwala
* Bret Taback
* Lee Cranmer
* Jose Lutzky
* Theresa L. Luna
* Sandra Aung
* David H. Lawson